Opportunities and challenges in applying microbiota to clinical cancer immunotherapy.

Fundamental research has elucidated the indispensable role of gut microbiota in modulating cancer immunotherapy efficacy. Despite promising preclinical findings, few related approaches have reached clinical trials. In this opinion, we provide insight…

Preview only. Read the full abstract at the source